About the WHO Programme for International Drug Monitoring

WHO Programme for International Drug Monitoring

The WHO PIDM is a global collaboration, launched in 1968, to monitor and improve the safety of medicines and vaccines.

What it means to be a member

The WHO PIDM provides a forum for WHO member states, territories, and areas to work together to improve medicines and vaccine safety. By sharing national insights, members help strengthen safety surveillance around the world.

UMC's role in the programme

As a WHO Collaborating Centre for International Drug Monitoring, UMC handles the operational aspects of the programme to promote safer use of medicines and vaccines globally.

Membership benefits

Gain from the experience of over 180 members and access to UMC's resources to support safer use of medicines and vaccines in your country.

How to join the programme

To become a member, you need to be prepared to contribute to the global database and share your experience and expertise within the global pharmacovigilance community.

Programme members

The programme includes over 180 WHO member states, territories, and areas.

VigiBase – the WHO global database

The world's largest source of post-marketing safety data is a rich resource for identifying and addressing safety issues both nationally and regionally.
Morty Proxy This is a proxified and sanitized view of the page, visit original site.